These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 35421933

  • 1. Celastrol mitigates staphyloxanthin biosynthesis and biofilm formation in Staphylococcus aureus via targeting key regulators of virulence; in vitro and in vivo approach.
    Yehia FAA, Yousef N, Askoura M.
    BMC Microbiol; 2022 Apr 15; 22(1):106. PubMed ID: 35421933
    [Abstract] [Full Text] [Related]

  • 2. Antibiofilm and staphyloxanthin inhibitory potential of terbinafine against Staphylococcus aureus: in vitro and in vivo studies.
    Askoura M, Yousef N, Mansour B, Yehia FAA.
    Ann Clin Microbiol Antimicrob; 2022 May 30; 21(1):21. PubMed ID: 35637481
    [Abstract] [Full Text] [Related]

  • 3. Hesperidin inhibits biofilm formation, virulence and staphyloxanthin synthesis in methicillin resistant Staphylococcus aureus by targeting SarA and CrtM: an in vitro and in silico approach.
    Vijayakumar K, Muhilvannan S, Arun Vignesh M.
    World J Microbiol Biotechnol; 2022 Jan 22; 38(3):44. PubMed ID: 35064842
    [Abstract] [Full Text] [Related]

  • 4. Candida albicans quorum-sensing molecule farnesol modulates staphyloxanthin production and activates the thiol-based oxidative-stress response in Staphylococcus aureus.
    Vila T, Kong EF, Ibrahim A, Piepenbrink K, Shetty AC, McCracken C, Bruno V, Jabra-Rizk MA.
    Virulence; 2019 Dec 22; 10(1):625-642. PubMed ID: 31280653
    [Abstract] [Full Text] [Related]

  • 5. Glyceryl trinitrate blocks staphyloxanthin and biofilm formation in Staphylococcus aureus.
    Abbas HA, Elsherbini AM, Shaldam MA.
    Afr Health Sci; 2019 Mar 22; 19(1):1376-1384. PubMed ID: 31148964
    [Abstract] [Full Text] [Related]

  • 6. Zinc oxide nanoparticles reduce biofilm formation, synergize antibiotics action and attenuate Staphylococcus aureus virulence in host; an important message to clinicians.
    Abdelghafar A, Yousef N, Askoura M.
    BMC Microbiol; 2022 Oct 11; 22(1):244. PubMed ID: 36221053
    [Abstract] [Full Text] [Related]

  • 7. A cholesterol biosynthesis inhibitor blocks Staphylococcus aureus virulence.
    Liu CI, Liu GY, Song Y, Yin F, Hensler ME, Jeng WY, Nizet V, Wang AH, Oldfield E.
    Science; 2008 Mar 07; 319(5868):1391-4. PubMed ID: 18276850
    [Abstract] [Full Text] [Related]

  • 8. Anti-Pathogenic Efficacy and Molecular Targets of a Polyherbal Wound- Care Formulation (Herboheal) Against Staphylococcus aureus.
    Patel P, Joshi C, Kothari V.
    Infect Disord Drug Targets; 2019 Mar 07; 19(2):193-206. PubMed ID: 30345928
    [Abstract] [Full Text] [Related]

  • 9. Small-molecule compound SYG-180-2-2 attenuates Staphylococcus aureus virulence by inhibiting hemolysin and staphyloxanthin production.
    Rao L, Xu Y, Shen L, Wang X, Zhao H, Wang B, Zhang J, Xiao Y, Guo Y, Sheng Y, Cheng L, Song Z, Yu F.
    Front Cell Infect Microbiol; 2022 Mar 07; 12():1008289. PubMed ID: 36310881
    [Abstract] [Full Text] [Related]

  • 10. Staphyloxanthin inhibitory potential of thymol impairs antioxidant fitness, enhances neutrophil mediated killing and alters membrane fluidity of methicillin resistant Staphylococcus aureus.
    Valliammai A, Selvaraj A, Muthuramalingam P, Priya A, Ramesh M, Pandian SK.
    Biomed Pharmacother; 2021 Sep 07; 141():111933. PubMed ID: 34328107
    [Abstract] [Full Text] [Related]

  • 11. Protective Effect of the Golden Staphyloxanthin Biosynthesis Pathway on Staphylococcus aureus under Cold Atmospheric Plasma Treatment.
    Yang Y, Wang H, Zhou H, Hu Z, Shang W, Rao Y, Peng H, Zheng Y, Hu Q, Zhang R, Luo H, Rao X.
    Appl Environ Microbiol; 2020 Jan 21; 86(3):. PubMed ID: 31704682
    [Abstract] [Full Text] [Related]

  • 12. Dehydrosqualene Desaturase as a Novel Target for Anti-Virulence Therapy against Staphylococcus aureus.
    Gao P, Davies J, Kao RYT.
    mBio; 2017 Sep 05; 8(5):. PubMed ID: 28874472
    [Abstract] [Full Text] [Related]

  • 13. Clemastine Inhibits the Biofilm and Hemolytic of Staphylococcus aureus through the GdpP Protein.
    Shang Y, Guo J, Zhao Y, Chen J, Meng Q, Qu D, Zheng J, Yu Z, Wu Y, Deng Q.
    Microbiol Spectr; 2022 Apr 27; 10(2):e0054121. PubMed ID: 35234502
    [Abstract] [Full Text] [Related]

  • 14. Network analytics approach towards identifying potential antivirulence drug targets within the Staphylococcus aureus staphyloxanthin biosynthetic network.
    Cueno ME, Imai K.
    Arch Biochem Biophys; 2018 May 01; 645():81-86. PubMed ID: 29551420
    [Abstract] [Full Text] [Related]

  • 15. Diclofenac mitigates virulence of multidrug-resistant Staphylococcus aureus.
    Abbas HA, Atallah H, El-Sayed MA, El-Ganiny AM.
    Arch Microbiol; 2020 Dec 01; 202(10):2751-2760. PubMed ID: 32737541
    [Abstract] [Full Text] [Related]

  • 16. The promising anti-virulence activity of candesartan, domperidone, and miconazole on Staphylococcus aureus.
    El-Ganiny AM, Gad AI, El-Sayed MA, Shaldam MA, Abbas HA.
    Braz J Microbiol; 2022 Mar 01; 53(1):1-18. PubMed ID: 34773629
    [Abstract] [Full Text] [Related]

  • 17. Attenuating the virulence of the resistant superbug Staphylococcus aureus bacteria isolated from neonatal sepsis by ascorbic acid, dexamethasone, and sodium bicarbonate.
    Saleh MM, Yousef N, Shafik SM, Abbas HA.
    BMC Microbiol; 2022 Nov 09; 22(1):268. PubMed ID: 36348266
    [Abstract] [Full Text] [Related]

  • 18. Diclofenac and Meloxicam Exhibited Anti-Virulence Activities Targeting Staphyloxanthin Production in Methicillin-Resistant Staphylococcus aureus.
    Elmesseri RA, Saleh SE, Ghobish SA, Majrashi TA, Elsherif HM, Aboshanab KM.
    Antibiotics (Basel); 2023 Jan 31; 12(2):. PubMed ID: 36830188
    [Abstract] [Full Text] [Related]

  • 19. Phosphonosulfonates are potent, selective inhibitors of dehydrosqualene synthase and staphyloxanthin biosynthesis in Staphylococcus aureus.
    Song Y, Lin FY, Yin F, Hensler M, Rodrígues Poveda CA, Mukkamala D, Cao R, Wang H, Morita CT, González Pacanowska D, Nizet V, Oldfield E.
    J Med Chem; 2009 Feb 26; 52(4):976-88. PubMed ID: 19191557
    [Abstract] [Full Text] [Related]

  • 20. Carvacrol Targets SarA and CrtM of Methicillin-Resistant Staphylococcus aureus to Mitigate Biofilm Formation and Staphyloxanthin Synthesis: An In Vitro and In Vivo Approach.
    Selvaraj A, Valliammai A, Muthuramalingam P, Priya A, Suba M, Ramesh M, Karutha Pandian S.
    ACS Omega; 2020 Dec 08; 5(48):31100-31114. PubMed ID: 33324819
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.